Velocity Sciences

Velocity Sciences is a private Boulder, Colorado biotechnology company focused on assay technologies and molecular recognition tools for diagnostic products. Public company-profile sources describe the business as developing next-generation diagnostic assays and proprietary technologies for targeting proteins, peptides, and small molecules. Third-party business databases also associate the company with aptamer, oligonucleotide, RNA synthesis, and directed-evolution capabilities, and Crunchbase additionally references therapeutic siRNA and lipid nanoparticle delivery technologies. Based on the available evidence, Velocity Sciences appears to be more of a platform and technology company than a clinical-stage therapeutics developer, with limited public disclosure of named drug candidates or human clinical programs.